APOBEC3B and gastric cancer: For example, Xia and colleagues reported that APOBEC3B upregulation predicts immune inactivation and worse survival in gastric cancer 56, while Serebrenik and colleagues reported that APOBEC3B is overexpressed in a subset of clear cell ovarian cancer and correlates with improved clinical outcomes 57.